Matisse Pharmaceuticals
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Matisse Pharmaceuticals Information
Geographic Data
Address:
City: Geleen
State: Limburg
Zip:
Country: The Netherlands
Financial Info
Stage:
series unknown
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
8,323,055Website Global Rank
418Website Monthly Traffic
Twitter Followers
Description
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Venture Round | 2 | $2M |
Chemelot Ventures Limburg Business Development Fund (LBDF) Chemelot Ventures Limburg Business Development Fund (LBDF) |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
